Skip to main content
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. — Investor Relations & Filings

Ticker · DARE ISIN · US23666P1012 US Manufacturing
Filings indexed 726 across all filing types
Latest filing 2026-04-28 Annual Report
Country US United States of America
Listing US DARE

About Dare Bioscience, Inc.

https://www.darebioscience.com/

Dare Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative products for women's health. The company conducts end-to-end clinical development of therapies designed to address unmet needs in areas such as contraception, sexual health, vaginal health, and menopause. Its pipeline includes candidates like Ovaprene®, a hormone-free monthly contraceptive, and a topical sildenafil cream for female sexual arousal disorder. Dare Bioscience emphasizes a rigorous, science-based approach to develop medically credible and evidence-based solutions, aiming to close critical gaps in female healthcare.

Recent filings

Filing Released Lang Actions
ARS - Dare Bioscience, Inc. (0001401914) (Filer)
Annual Report
2026-04-28 English
DEF 14A - Dare Bioscience, Inc. (0001401914) (Filer)
Proxy Solicitation & Information Statement
2026-04-28 English
8-K - Dare Bioscience, Inc. (0001401914) (Filer)
Regulatory Filings
2026-04-22 English
8-K - Dare Bioscience, Inc. (0001401914) (Filer)
Regulatory Filings
2026-04-17 English
8-K - Dare Bioscience, Inc. (0001401914) (Filer)
Regulatory Filings
2026-04-13 English
10-K - Dare Bioscience, Inc. (0001401914) (Filer)
Annual Report
2026-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.